GE HealthCare Valuation
| GEHC Stock | 82.44 0.74 0.91% |
At this time, the firm appears to be undervalued. GE HealthCare Techno owns a latest Real Value of USD90.24 per share. The recent price of the firm is USD82.44. Our model calculates the value of GE HealthCare Techno from inspecting the firm fundamentals such as Operating Margin of 0.17 %, shares owned by insiders of 0.20 %, and Return On Asset of 0.0577 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GE HealthCare's valuation include:
Price Book 4.4235 | Enterprise Value | Enterprise Value Ebitda 11.9649 | Price Sales 1.8992 | Forward PE 17.3611 |
Undervalued
Today
Please note that GE HealthCare's price fluctuation is very steady at this time. Calculation of the real value of GE HealthCare Techno is based on 3 months time horizon. Increasing GE HealthCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GE HealthCare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GEHC Stock. However, GE HealthCare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 82.44 | Real 90.24 | Target 96.76 | Hype 81.62 | Naive 82.28 |
The real value of GEHC Stock, also known as its intrinsic value, is the underlying worth of GE HealthCare Techno Company, which is reflected in its stock price. It is based on GE HealthCare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GE HealthCare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GE HealthCare Technologies helps investors to forecast how GEHC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GE HealthCare more accurately as focusing exclusively on GE HealthCare's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GE HealthCare's intrinsic value based on its ongoing forecasts of GE HealthCare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GE HealthCare's closest peers. If more than one evaluation category is relevant for GE HealthCare we suggest using both methods to arrive at a better estimate.
GE HealthCare Cash |
|
GEHC Valuation Trend
Comparing GE HealthCare's enterprise value against its market capitalization is a good way to estimate the value of GE HealthCare Technologies uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
GEHC Revenue by Product
GE HealthCare Total Value Analysis
GE HealthCare Technologies is currently forecasted to have valuation of 43.86 B with market capitalization of 37.36 B, debt of 1.5 B, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GE HealthCare fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
43.86 B | 37.36 B | 1.5 B |
GE HealthCare Investor Information
About 88.0% of the company shares are owned by institutional investors. The book value of GE HealthCare was currently reported as 18.48. The company has Price/Earnings To Growth (PEG) ratio of 2.14. GE HealthCare Techno last dividend was issued on the 14th of January 2025. Based on the measurements of operating efficiency obtained from GE HealthCare's historical financial statements, GE HealthCare Technologies is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.15 | 0.1334 |
|
| |||||
| Total Cash From Operating Activities | 2.1 B | 2 B |
|
| |||||
| Operating Income | 2.8 B | 2.6 B |
|
|
GE HealthCare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. GE HealthCare has an asset utilization ratio of 59.45 percent. This indicates that the Company is making USD0.59 for each dollar of assets. An increasing asset utilization means that GE HealthCare Technologies is more efficient with each dollar of assets it utilizes for everyday operations.GE HealthCare Ownership Allocation
GE HealthCare Techno secures a total of 457.3 Million outstanding shares. The majority of GE HealthCare Techno outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to purchase positions in GE HealthCare Technologies to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in GE HealthCare Techno. Please pay attention to any change in the institutional holdings of GE HealthCare as this could imply that something significant has changed or is about to change at the company. On January 23, 2023, Representative Austin Scott of US Congress acquired under $15k worth of GE HealthCare Techno's common stock.GE HealthCare Profitability Analysis
The company reported the previous year's revenue of 19.67 B. Net Income was 2.05 B with profit before overhead, payroll, taxes, and interest of 8.21 B.GE HealthCare Past Distributions to stockholders
| 14th of February 2025 | ||
| 15th of November 2024 | ||
| 15th of August 2024 | ||
| 15th of May 2024 | ||
| 15th of February 2024 | ||
| 15th of November 2023 | ||
| 15th of August 2023 | ||
| 15th of June 2023 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GE HealthCare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GE HealthCare and how it compares across the competition.
About GE HealthCare Valuation
The stock valuation mechanism determines GE HealthCare's current worth on a weekly basis. Our valuation model uses a comparative analysis of GE HealthCare. We calculate exposure to GE HealthCare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GE HealthCare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 8.2 B | 8 B | |
| Pretax Profit Margin | 0.13 | 0.15 | |
| Operating Profit Margin | 0.13 | 0.15 | |
| Net Profit Margin | 0.10 | 0.11 | |
| Gross Profit Margin | 0.42 | 0.32 |
A single share of GE HealthCare represents a small ownership stake in the entity. As a stockholder of GEHC, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
GE HealthCare Dividends Analysis For Valuation
At present, GE HealthCare's Dividend Paid And Capex Coverage Ratio is projected to slightly decrease based on the last few years of reporting. . At present, GE HealthCare's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 55 M | 57.8 M | |
| Dividend Payout Ratio | 0.03 | 0.02 | |
| Dividend Paid And Capex Coverage Ratio | 4.28 | 6.41 |
There are various types of dividends GE HealthCare can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of GEHC shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from GE HealthCare Technologies directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When GEHC pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of GE HealthCare by the value of the dividends paid out.
GE HealthCare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 459 M | |
| Quarterly Earnings Growth Y O Y | 0.784 | |
| Forward Price Earnings | 17.3611 |
GE HealthCare Current Valuation Indicators
Valuation refers to the process of determining the present value of GE HealthCare Technologies and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value GEHC we look at many different elements of the entity such as GEHC's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GE HealthCare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GE HealthCare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GE HealthCare's worth.Complementary Tools for GEHC Stock analysis
When running GE HealthCare's price analysis, check to measure GE HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GE HealthCare is operating at the current time. Most of GE HealthCare's value examination focuses on studying past and present price action to predict the probability of GE HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GE HealthCare's price. Additionally, you may evaluate how the addition of GE HealthCare to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |